Salidroside alleviates dexamethasone‐induced inhibition of bone formation via transforming growth factor‐beta/Smad2/3 signaling pathway-Reference-Cited by-同舟云学术

Salidroside alleviates dexamethasone‐induced inhibition of bone formation via transforming growth factor‐beta/Smad2/3 signaling pathway

Published:2022-12-25 Issue: Volume: Page:
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Xie Baocheng¹²,Zhou Huan¹³,Liu Hongyu¹³,Liao Shiyi¹³,Zhou Chenhui⁴,Xu Daohua¹³^ORCID

Affiliation:

1. Guangdong Key Laboratory for Research and Development of Natural Drugs, School of Pharmacy Guangdong Medical University Zhanjiang People's Republic of China

2. Department of Pharmacy, Affiliated Dongguan Hospital Southern Medical University Dongguan People's Republic of China

3. Key Laboratory of Traditional Chinese Medicine and New Pharmaceutical Development, Department of Pharmacology Guangdong Medical University Dongguan People's Republic of China

4. School of Nursing Guangdong Medical University Dongguan People's Republic of China

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7711

Reference33 articles.

1. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research